Mitogenic signaling by lysophosphatidic acid (LPA) involves Galpha12

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• Lysophosphatidic acid (LPA) is a serum-derived ligand that activates G protein-coupled receptors (GPCRs), including those coupled to G(i), G(q), and G12/13.
• Overexpression of Galpha12 (Galpha12WT) induces serum-dependent oncogenic transformation in NIH3T3 cells.
• LPA's potent growth-stimulating activity suggests a role in serum-mediated neoplastic transformation.

Purpose of the Study:

• To investigate the hypothesis that serum-dependent neoplastic transformation of Galpha12WT-NIH3T3 cells is mediated by LPA-receptor (LPAR) stimulation.
• To elucidate the signaling pathway linking LPAR, Galpha12, and downstream effectors in cell proliferation.

Main Methods:

• Guanine nucleotide exchange assay and GST-TPR binding assay to assess Galpha12 activation by LPA.
• Assays for JNK activation, DNA synthesis, and cell proliferation in response to LPA.
• Treatment with suramin, a receptor-uncoupling agent, to evaluate the role of cell surface LPAR signaling.

Main Results:

• LPA treatment (2 μM) activated Galpha12 in Galpha12WT-NIH3T3 cells.
• LPA stimulated JNK activation, DNA synthesis, and proliferation, substituting for serum.
• LPA-mediated proliferation involved Galpha12, not Galpha13, and was inhibited by suramin, indicating LPAR-Galpha12 signal coupling.

Conclusions:

• LPA signaling through LPARs and Galpha12 is a critical mediator of serum-dependent neoplastic transformation in NIH3T3 cells.
• Understanding the LPAR-Galpha12 signaling axis provides insights into oncogenic pathways.
• This mechanistic understanding may identify novel therapeutic targets for cancer treatment.